Three years after Pfizer Inc. (NYSE:PFE) dropped a bombshell on its plans to lay off more than 1000 workers. The biopharmaceutical company has come back with some of the best news, on how it plans to use the vacated Groton site. In a joint announcement, Gov. Dannel P. Malloy and Pfizer confirmed that two buildings…
AbbVie, Inc. (NYSE:ABBV) announced the initiation of a pivotal Phase 3 clinical trial that will evaluate the use of HUMIRA (adalimumab) as a treatment for fingernail psoriasis in patients with moderate to severe chronic plaque psoriasis, an area of unmet need. Currently there are no approved treatments for fingernail psoriasis. AbbVie Inc (NYSE:ABBV) stock performance…
AbbVie Inc. (NYSE:ABBV) rival Gilead makes exclusive deal with CVS for hep C drugs. The deal blocks North Chicago-based AbbVie Inc.’s treatment, called Viekira Pak, which will only be available to patients given approval because of medical exceptions or through a process called prior authorization, according to CVS. Patients already taking Viekira Pak will be…
On Dec. 23, AbbVie (NYSE:ABBV) will participate in the Goldman Sachs Healthcare CEOs Unscripted Conference on Tuesday, Jan. 6, 2015. Richard A. Gonzalez, chairman and chief executive officer, will take part in a question and answer session at 2:15 p.m. Central time. AbbVie Inc. (NYSE:ABBV) belongs to Healthcare sector. Its net profit margin is 18.90%…
Wells Fargo & Company (NYSE:WFC)’s Wealth, Brokerage and Retirement (WBR) division today announced the launch of Wells Fargo Investment Institute (WFII). WFII brings together the investment research, strategy, manager research and publications teams from WBR’s four lines of business to create a single group with a goal of providing world-class advice to the company’s financial…
AbbVie (NYSE:ABBV) said that it presented new results from a Phase 2 study of investigational compound venetoclax (ABT-199/GDC-0199) in patients with acute myelogenous leukemia or AML at the 56th American Society of Hematology Annual Meeting. AbbVie Inc. (NYSE:ABBV) belongs to Healthcare sector. Its net profit margin is 18.90% and weekly performance is 0.74%. On last…
